About NovellusDx
NovellusDx is a company based in Jerusalem (Israel) founded in 2011.. NovellusDx has raised $85.5 million across 4 funding rounds from investors including Novartis, Orbimed and GSK. NovellusDx operates in a competitive market with competitors including GRAIL, Color, Omniome, Earli and NeoGenomics, among others.
- Headquarter Jerusalem, Israel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$85.5 M (USD)
in 4 rounds
-
Latest Funding Round
$57 M (USD), Series C
Sep 21, 2020
-
Investors
Novartis
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NovellusDx
NovellusDx has successfully raised a total of $85.5M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $57 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $57.0M
-
First Round
First Round
(23 Dec 2015)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Series C - NovellusDx | Valuation | Pontifax , Orbimed | |
| Apr, 2018 | Amount | Series B - NovellusDx | Valuation | 3B FUTURE Health Fund , Windham Venture Partners |
|
| Jun, 2016 | Amount | Series B - NovellusDx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NovellusDx
NovellusDx has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, Orbimed and GSK. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pontifax Venture Capital is focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Life sciences focused VC firm funding companies in the US and Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NovellusDx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NovellusDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novellusdx Comparisons
Competitors of NovellusDx
NovellusDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Color, Omniome, Earli and NeoGenomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
Early cancer detection tests are developed using synthetic biomarkers.
|
|
| domain | founded_year | HQ Location |
Cancer genetic diagnostic services are provided through specialized lab networks.
|
|
| domain | founded_year | HQ Location |
New genome engineering technology is provided for treating multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novellusdx
Frequently Asked Questions about NovellusDx
When was NovellusDx founded?
NovellusDx was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Where is NovellusDx located?
NovellusDx is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Is NovellusDx a funded company?
NovellusDx is a funded company, having raised a total of $85.5M across 4 funding rounds to date. The company's 1st funding round was a Series B of $12.5M, raised on Dec 23, 2015.
What does NovellusDx do?
NovellusDx was founded in 2011 in Jerusalem, Israel, within the biotechnology sector focused on precision medicine. Technology is developed to track outcomes of DNA mutations, assess their functional and clinical impacts, and evaluate drug effects on specific tumors. Operations center on advancing diagnostic and therapeutic tools for oncology, with applications in personalized cancer treatment strategies.
Who are the top competitors of NovellusDx?
NovellusDx's top competitors include GRAIL, Tessera Therapeutics and Phase Genomics.
Who are NovellusDx's investors?
NovellusDx has 10 investors. Key investors include Novartis, Orbimed, GSK, HBM Healthcare Investments, and Pontifax Venture Capital.